An interventional study of Diclofenac hydroxyethylpyrrolidine and orphenadrine in Pain Relief, sponsored by Western Galilee Hospital-Nahariya. Withdrawn. Open to participants aged 15 Years to 100 Years. Per ClinicalTrials.gov, last updated 2020-05-27.
Sponsored by Western Galilee Hospital-Nahariya · Not applicable, Interventional, and Treatment
The investigators will conduct a randomized double blind study, to determine whether patient analgesic delivery mode preference affects pain reduction quality in non-surgical spine patients.
The patients will receive both intra-muscular and oral non-narcotic analgesics and placebo. During the study period, pain reduction parameters will be collected. At the end of the study period, the investigators will attempt to find a correlation between pre-study patient preferences and the quality of the pain reduction achieved.
Western Galilee Hospital-Nahariya is the lead sponsor of 87 studies on the registry; 16 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Patients receiving intra-muscular medication and oral placebo
Drug: Diclofenac hydroxyethylpyrrolidine · Drug: orphenadrine · Drug: Tramadol · Drug: Dipyrone
Patients receiving intra-muscular placebo and oral medication
Drug: Diclofenac hydroxyethylpyrrolidine · Drug: orphenadrine · Drug: Tramadol · Drug: Dipyrone
IM/PO
Also known as: Voltaren, Abitren
IM/PO orphenadrine
Also known as: Flexin
IM/PO tramadol
Also known as: Tramadex, Tramal
PO/IM Dipyrone
Also known as: Optalgin, Phanalgin
pain scores on visual analog scale
up to 7 days for each patient per hospitalization
Time frame: visual analog scale will be mesuered before and one hour following every pain medication delivery
Patient Questionnaire assessing pain and pain relief
A questionnaire will be filled immediately before and one hour following analgesic administration
Time frame: Before administaration of pain control medication and one hour following analgesic administration
patient preference Questionnaire
every patient will be asked for his prefered analgesic delivery method
Time frame: before first analgesic administration at the current hositalization
No study locations are listed for this record.
This study is withdrawn, as verified in May 2020. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Western Galilee Hospital-Nahariya